Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

Ken Hall takes a closer look at GSK after the FTSE 100 pharmaceutical giant's positive first quarter earnings update.

McKesson Corporation announced its intention to separate its Medical-Surgical Solutions segment into an independent company.

President Donald Trump’s latest bid to slash prescription drug prices has once again stirred heated debate about the high costs paid by U.S. patients.

President Donald Trump’s plan to change the pricing model for some medications is facing fierce criticism from the ...

President Donald Trump says he'll sign an executive order on Monday that, if implemented, could bring down the costs of some ...

Billionaire pharmaceuticals company owner Dennis Bastas is firming as the likely buyer behind Melbourne's priciest ever home ...

The ink on Britain’s landmark post-Brexit trade deal with India had hardly dried before the news broke that an agreement with ...

The pharmaceutical industry estimates President Donald Trump’s new drug pricing proposal could cost drug companies as much as $1 trillion over a decade, its largest trade group is telling members of ...

Currently, Ascendis Pharma has a market capitalization of $10.26 billion. Buying $1000 In ASND: If an investor had bought $1000 of ASND stock 15 years ago, it would be worth $68,514.06 today based ...

QNX report claims robotics market will more than triple by 2030 Automation and production are the most common applications Despite safety improvements, many report having experienced safety issues ...

Are pharmaceutical companies earning too much? Deciding whether pharmaceutical companies earn too much money is complicated. In this issue of JAMA, 2 reports take different approaches to the question.